| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/31/2006 | WO2006090874A1 Method of analyzing mammalian t cell cytokines, method of evaluating all of related diseases and analysis of prevention and therapy therefor |
| 08/31/2006 | WO2006090853A1 Nitrogenous heterocyclic compound and medicinal use thereof |
| 08/31/2006 | WO2006090833A1 Transdermal preparation for external use containing nonsteroidal antiinflammatory/analgesic agent |
| 08/31/2006 | WO2006090817A1 Indole compound and use thereof |
| 08/31/2006 | WO2006090813A1 Element retained in blood showing degradability selectively in tumor tissue |
| 08/31/2006 | WO2006090756A1 Novel preventive or remedy for lipid metabolism disorder, obesity and diabetes and use therefor |
| 08/31/2006 | WO2006090150A1 Pharmaceutical composition comprising amorphous rosiglitazone |
| 08/31/2006 | WO2005051318A3 Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 08/31/2006 | WO2005030118A3 Targeted release of nitric oxide in the cns circulation for modulating the bbb and treating disorders |
| 08/31/2006 | WO2005010163A3 Compositions and methods for immunotherapy of human immunotherapy of human immunodeficiency virus (hiv) |
| 08/31/2006 | US20060195917 Non-mammalian transgenic animal having an adult onset neurodegenerative phenotype |
| 08/31/2006 | US20060194868 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and /or congestive heart failure |
| 08/31/2006 | US20060194855 Method of treating migraines and pharmaceutical compositions |
| 08/31/2006 | US20060194818 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/31/2006 | US20060194797 Condensed ring compound and use thereof |
| 08/31/2006 | US20060194793 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/31/2006 | US20060194792 1-Cyclic carbonyl-4-(4-quinoline-)-1,4-diazepine or 1-cyclic carbonyl-4-[4-(1H-quinolin-2-{thio}one)-1,4-diazepinone derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment |
| 08/31/2006 | US20060194766 Combinations comprising anti-epileptic drugs for the treatment of neurological disorders |
| 08/31/2006 | US20060194755 Compositions and methods for regulating an immune response in a subject |
| 08/31/2006 | US20060194742 Pyrane derivatives as both ACE- and NEP-inhibitors |
| 08/31/2006 | US20060194731 Using tumor antigens to elicit immune response targeted to cancer cells; immunotherapy |
| 08/31/2006 | US20060194340 Also, utilization of mass spectrometry (e.g., Surface Enhanced Laser Desorption Ionization, Maldi Qq TOF, MS/MS, TOF TOF, ESI-Q-TOF or ION-TRAP) to elucidate particular indicative or predictive biopolymer markers |
| 08/31/2006 | US20060194338 Characterizing the existence of a disease state; particularly to the utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state |
| 08/31/2006 | US20060194293 Rb1 gene induced protein (rb1cc1) and gene |
| 08/31/2006 | US20060193925 such as pioglitazone, troglitazone, rosiglitazone; plant extracts of Ephedrae Herba, Glycyrrhizae Radix and Gypsum Fibrosum in powder form; reduces body weight gain effect |
| 08/31/2006 | US20060193904 Encapsulation of drugs in liposomes; encapsulated transition metal ions and encapsulated drugs, where if the drug is soley doxorubicin, the metal ion is not solely manganese, and the liposomes do not comprise an ionophore |
| 08/31/2006 | US20060193877 Compositions and methods of making sustained release liquid formulations |
| 08/31/2006 | US20060193871 transmission and, or amplification of signal; oral or enteric administering, dissolving, absorption; peptide yy; obesity therapy |
| 08/31/2006 | US20060193835 Treatment of congestive heart failure |
| 08/31/2006 | US20060193826 Methods to mobilize progenitor/stem cells |
| 08/31/2006 | US20060193790 Promoting whole body health |
| 08/31/2006 | US20060193772 Drugs for treating cancer |
| 08/31/2006 | DE10335845B4 Pheromone als Antikrebsmittel Pheromones as anticancer agents |
| 08/31/2006 | CA2599348A1 Indole compound and use thereof |
| 08/31/2006 | CA2599115A1 Novel combinational use of sulfonamide compound |
| 08/31/2006 | CA2571982A1 Methods of modulating intracellular degradation rates of toxins |
| 08/30/2006 | EP1696030A1 TIE ligand homologues |
| 08/30/2006 | EP1696029A1 TIE ligand homologues |
| 08/30/2006 | EP1695991A1 Coordination complex of diaminocyclohexaneplatinum(ii) with block copolymer containing poly(carboxylic acid) segment and antitumor agent comprising the same |
| 08/30/2006 | EP1695986A2 Anti-erb B2 antibodies |
| 08/30/2006 | EP1695980A2 Human papillomavirus E2 transactivation domain / inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket |
| 08/30/2006 | EP1695719A1 Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery |
| 08/30/2006 | EP1695716A2 Medicinal compositions containing diuretics and insulin sensitizers |
| 08/30/2006 | EP1695712A2 Oral formulations for the selective inhibition of thrombin comprising boronic acid species |
| 08/30/2006 | EP1695711A2 Parenteral formulations comprising boronic acid species for selective thrombin inhibition |
| 08/30/2006 | EP1695706A1 Medicinal compositions and combinations |
| 08/30/2006 | EP1695698A1 Anti-angiogene compositions and methods of use |
| 08/30/2006 | EP1695697A1 Anti-angiogenic compositions and methods of use |
| 08/30/2006 | EP1695691A2 Foaming composition for hair cleaning and hair treatment |
| 08/30/2006 | EP1694841A2 Cancer treatment |
| 08/30/2006 | EP1694826A1 Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers |
| 08/30/2006 | EP1694357A1 Use of cathepsin s inhibitors for treating an immune response caused by administration of a small molecule therapeutic or biologic |
| 08/30/2006 | EP1694338A2 Use of superoxide dismutase mimetics and reductase glutathione in the form of anticancer drugs |
| 08/30/2006 | EP1694337A2 Topical use of halosalicylic acid derivatives |
| 08/30/2006 | EP1694328A2 Methods and compositions for the treatment and management of hemoglobinopathy and anemia |
| 08/30/2006 | EP1694313A2 Tellurium derivatives for prevention and treatment of neurodegenerative processes |
| 08/30/2006 | EP1694301A2 Methods and compositions for the production of monoclonal antibodies |
| 08/30/2006 | EP1694273A2 Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption |
| 08/30/2006 | EP1694139A1 Method for the preparation of multi-component mineral preparations |
| 08/30/2006 | EP1608407B1 Dispersible formulation of an anti-inflammatory agent |
| 08/30/2006 | EP1490477A4 Redifferentiated cells for repairing cartilage defects |
| 08/30/2006 | EP1421198A4 Cell-based high-throughput screening methods |
| 08/30/2006 | EP1399128B1 Composition for the treatment of diseases which affect animals' hooves |
| 08/30/2006 | EP1377298B1 Exemestane for treating hormono-dependent disorders |
| 08/30/2006 | EP1333842B1 Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders |
| 08/30/2006 | EP1272183B1 Methods and compositions useful in enhancing oxygen delivery to cells |
| 08/30/2006 | EP1266008B1 Acute neuronal induced calcium binding protein type 1 ligand |
| 08/30/2006 | EP1254260B1 Methods for diagnosing and treating heart disease |
| 08/30/2006 | EP1180524B1 Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides |
| 08/30/2006 | EP1143958B1 Pharmaceutical composition and use of rnsaid for treating inflammation |
| 08/30/2006 | EP0793489B9 Use of statin for the treatment of skin disorders |
| 08/30/2006 | CN1826317A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor |
| 08/30/2006 | CN1826140A Combination therapy for the treatment of bacterial infections |
| 08/30/2006 | CN1826107A Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator |
| 08/30/2006 | CN1824320A Medicinal composition containing calcium passage paralysor and B family vitamin and its use |
| 08/30/2006 | CN1824319A Hormone kind anticancer medicine slow release agent |
| 08/30/2006 | CN1824318A Slow release implantation agent for anticancer |
| 08/30/2006 | CN1824317A Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents |
| 08/30/2006 | CN1824316A Liquid used for inhibiting bacterial infection and promoting skin growth |
| 08/30/2006 | CN1824315A Synergistic therapeutic compositions and methods |
| 08/30/2006 | CN1824314A Slow release agent containing hormone kind anti cancer medicine |
| 08/30/2006 | CN1824313A Slow release microsphere containing hormone kind anti cancer medicine and its application |
| 08/30/2006 | CN1824312A Compound medicine for preventing and treating cardio vascular cerebral vascular disease and its application |
| 08/30/2006 | CN1824311A Preparation for the prophylaxis of restenosis |
| 08/30/2006 | CN1824310A Preparation method of medicine for treating pelada |
| 08/30/2006 | CN1824290A Therapeutic compound joint synovia and its preparation method |
| 08/30/2006 | CN1824289A Use of substance P for mobilization or proliferation of mesenchymal stem cells and for wound healing or accelerating wound healing |
| 08/30/2006 | CN1823817A Electrolyte nutrition fortification agent |
| 08/30/2006 | CN1823780A Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 08/30/2006 | CN1823758A Compounds and methods of treating transplant rejection |
| 08/30/2006 | CN1823743A Self emulsified osmotic pump controlled release administration system of liposoluble medicine and its preparation technology |
| 08/30/2006 | CN1823738A Powder ampoule agent for injection and its preparation method |
| 08/30/2006 | CN1823731A Esters of l-carnitine of alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 08/30/2006 | CN1823728A Fast film forming medical film coating liquid possessing antiseptic and/or treating action |
| 08/30/2006 | CN1272345C Silensed anti-CD 28 antibodies and use thereof |
| 08/30/2006 | CN1272328C Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 08/30/2006 | CN1272024C Use of dietary additives for preparing medicament for treating malignancies and viral infections and improving immunologic function |
| 08/30/2006 | CN1271993C New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof |
| 08/29/2006 | US7098375 Animal and cell models for type II diabetes and their use |
| 08/29/2006 | US7098343 Polycyclic compounds containing a central trivalent atom to which is attached either direct or indirectly via a linker a two or three ring system and a ring system contining sulphamate group as substituent; steroid sulfatase inhibitor |